Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16921061 | 0.93 | TSHR (0.32) | TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL13197154 | 0.87 | TSHR (0.44) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL22522293 | 0.79 | TSHR (0.33) | TSHRHPGDALDH1A1CYP3A4 | |
| Hydrochloric Acid SCHEMBL11572388 | 0.77 | TSHR (0.44) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL16985044 | 0.76 | TSHR (0.36) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL22522317 | 0.75 | TSHR (0.38) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL21404661 | 0.75 | TSHR (0.50) | TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL16985059 | 0.75 | TSHR (0.45) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL71730 | 0.74 | TSHR (0.59) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL21404624 | 0.74 | TSHR (0.49) | TSHRHPGDALDH1A1CYP3A4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180134912-A1 | UREA (MULTI)-URETHANE (METH)ACRYLATE-SILANE COMPOSITIONS AND ARTICLES INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES CO (US) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134912-A1 | UREA (MULTI)-URETHANE (METH)ACRYLATE-SILANE COMPOSITIONS AND ARTICLES INCLUDING THE SAME | RCOR1, RUVBL1, RER1 | TSHR 1272/4885HPGD 4194/4885ALDH1A1 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.